Isn't it great (and telling) that Bozo gets to blow another million or two this quarter on their 3rd rate diabetes testing products, and with no exaggeration, not ONE shareholder even cares or discusses quarterly results.
It's "oh we're coming up with coronavirus tests, the results for the rest of the business don't matter."
If he were smart, he take a nice payment from the DECN bank, and book a nice, even bigger loss. His shareholders will smile at him while he does it. Guess we will see 2Q results in a couple of weeks.